MINocyclinE to Reduce inflammation and blood‐brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double‐blind, placebo‐controlled experimental medicine trial

Abstract INTRODUCTION Cerebral small vessel disease (SVD) is a common cause of stroke/vascular dementia with few effective treatments. Neuroinflammation and increased blood-brain barrier (BBB) permeability may influence pathogenesis. In rodent models, minocycline...

CNS 2024: Day 4 Highlights

We closed out CNS 2024 in Toronto with another excellent poster session, followed by a whopping 6 more symposia, including  on the production of language nd a special session in honor of Endel Tulving about the modern science of memory. Check out some highlights in...